Literature DB >> 2984143

Oncogene expression in isogenic, EBV-positive and -negative Burkitt lymphoma cell lines.

P M Glazer, W C Summers.   

Abstract

To elucidate the mode of action of Epstein-Barr virus (EBV), we have examined the possibility that EBV infection may lead to a change in oncogene expression. Levels of oncogene-related RNA were compared in the Burkitt lymphoma(BL)-derived, EBV-negative cell line BJAB and in two isogenic, EBV-converted sublines of BJAB whose growth characteristics differ from the EBV-negative parent line. The oncogenes c-myc, Ha-ras, and Blym were each found to be expressed at equally high levels in the three cell lines. This suggests that the mechanism of action of EBV in altering the growth properties of lymphoid cells is not dependent on the induction of cellular oncogenes. In addition, since the 8,14 chromosomal translocation has been related to increased c-myc expression in BL cells, a karyotype analysis was done to confirm the initial report of a normal karyotype in BJAB cells. Chromosomes 8 and 14 were seen to be normal. Thus, BJAB cells are a BL cell line in which the elevated expression of c-myc is independent not only of EBV but also of translocations involving chromosome 8.

Entities:  

Mesh:

Year:  1985        PMID: 2984143     DOI: 10.1159/000149589

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  4 in total

1.  Induction of c-myc expression in human B lymphocytes by B-cell growth factor and anti-immunoglobulin.

Authors:  J Lacy; S N Sarkar; W C Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

2.  Amplification and deregulation of MYC following Epstein-Barr virus infection of a human B-cell line.

Authors:  J Lacy; W P Summers; M Watson; P M Glazer; W C Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells.

Authors:  Ping Zou; Junichi Kawada; Lesley Pesnicak; Jeffrey I Cohen
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

Review 4.  LMP1 and Dynamic Progressive Telomere Dysfunction: A Major Culprit in EBV-Associated Hodgkin's Lymphoma.

Authors:  Hans Knecht; Sabine Mai
Journal:  Viruses       Date:  2017-06-27       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.